19250 NE Portal Way, Portland, OR 97230 +1 310 455 9876

Blog

CRISPR cancer trial success paves the way for personalized treatments

CRISPR cancer trial success paves the way for personalized treatments
‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumors. A small clinical trial has shown that researchers can use CRISPR gene editing to alter immune cells so that they will recognize mutated proteins specific to a person’s tumours. Those cells can then be safely set loose in the body to find and…
Read more

Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-Phase Research to the Clinic

Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-Phase Research to the Clinic
Synthego, the genome engineering company, today announced it has raised $200 million of growth capital, including a Series E financing led by Perceptive Advisors. Also participating in the round were new investors SoftBank Vision Fund 2, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund and Chimera Abu Dhabi and existing investors Wellington Management, RA Capital…
Read more

Lettuce Developed With CRISPR/Cas Gene Editing Tech Boosts Nutrients

Lettuce Developed With CRISPR/Cas Gene Editing Tech Boosts Nutrients
Classic breeding methods such as mutagenesis or hybridization have been the foundation for plant breeding, where spontaneous mutations and recombination are utilized for plant genetic improvement. While random mutagenesis can create many mutations across a plant species’ genome, many of the mutations are deleterious, resulting in undesirable traits. Similarly, traditional breeding through introgression of desirable…
Read more